Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 27/01/21 → 26/01/22 |
Funding
- TAXIS Pharmaceuticals, Inc.: $55,948.86
Keywords
- Biotechnology & Drug Development, Infectious Diseases
Taxis 2021-01: Efficacy of a Novel Efflux Pump Inhibitors with Levofloxacin in the Murine Lung and Thigh Infection Models with P. aeruginosa
- Weiss, William (PI)